Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BHVN
#1901
Biohaven Ltd. Common Shares
15.4
0
USD
-0.04%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-4.47%
Monthly Change
+14.41%
6 month change
+36.46%
Year Change
-9.10%
Previous Close
16.1
2
Open
15.2
8
Low
14.9
4
High
15.4
5
Volume
1 581
Markets
US Stock Market
Healthcare
Biotechnology
BHVN
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
2022
Current report, Q3 FY2022
2022.09.28
Biohaven Ltd. current report, Q3 FY2022
8-K
1
2
3
4
5
6
7
News
Biohaven: Buy Reiterated On Opakalim License Agreement For Epilepsy And More (NYSE:BHVN)
Biohaven: Sale Of Opakalim Rights To SK Biopharmaceuticals Makes Sense (NYSE:BHVN)
BHVN Stock Soars 18% on $795M Out-Licensing Deal for Epilepsy Program
Why Is Biohaven Stock Soaring Wednesday? - Biohaven (NYSE:BHVN)
Stay Bullish Despite The Rough Week: Aerospace, Finance, Biotech, And AI (NDX)
Biohaven: Nice Pipeline Momentum, But Its Runway Is A Risk (NYSE:BHVN)
Biohaven: Upgrading To Buy On Protein Degraders Pivotal Study Initiations (BHVN)
Biotech Stocks Surge As UniQure 'Nail-Biting Journey' Comes To An End
Why Is TG Therapeutics (TGTX) Down 5.7% Since Last Earnings Report?
Myriad (MYGN) Up 7.1% Since Last Earnings Report: Can It Continue?
Biohaven - Despite Today's Gains, I Remain Skeptical (NYSE:BHVN)
Biohaven Ltd. (BHVN) Upgraded to Buy: Here's Why